Biofrontera Future Growth
Future criteria checks 5/6
Biofrontera is forecast to grow earnings and revenue by 48% and 22.4% per annum respectively while EPS is expected to grow by 45.3% per annum.
Key information
48.0%
Earnings growth rate
45.3%
EPS growth rate
Pharmaceuticals earnings growth | 20.6% |
Revenue growth rate | 22.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 40 | 3 | 1 | 2 | 1 |
12/31/2023 | 31 | 0 | -4 | -3 | 1 |
12/31/2022 | 26 | -38 | -9 | -9 | 1 |
9/30/2022 | 32 | 11 | N/A | N/A | N/A |
6/30/2022 | 31 | 10 | 33 | 33 | N/A |
3/31/2022 | 30 | 15 | N/A | N/A | N/A |
12/31/2021 | 29 | 38 | 30 | 30 | N/A |
9/30/2021 | 28 | -16 | N/A | N/A | N/A |
6/30/2021 | 27 | -16 | -8 | -7 | N/A |
3/31/2021 | 29 | -12 | N/A | N/A | N/A |
12/31/2020 | 30 | -13 | -4 | -3 | N/A |
9/30/2020 | 33 | -17 | N/A | N/A | N/A |
6/30/2020 | 33 | -22 | -14 | -12 | N/A |
3/31/2020 | 31 | -10 | N/A | N/A | N/A |
12/31/2019 | 31 | -7 | -35 | -33 | N/A |
9/30/2019 | 26 | 1 | N/A | N/A | N/A |
6/30/2019 | 26 | 8 | -29 | -28 | N/A |
3/31/2019 | 23 | -8 | N/A | N/A | N/A |
12/31/2018 | 21 | -9 | -14 | -13 | N/A |
9/30/2018 | 19 | -14 | -13 | -13 | N/A |
6/30/2018 | 16 | -15 | -12 | -12 | N/A |
3/31/2018 | 14 | -16 | N/A | N/A | N/A |
12/31/2017 | 12 | -16 | -14 | -13 | N/A |
9/30/2017 | 11 | -18 | -16 | -16 | N/A |
6/30/2017 | 9 | -16 | -16 | -16 | N/A |
3/31/2017 | 8 | -14 | -15 | -15 | N/A |
12/31/2016 | 6 | -11 | -11 | -10 | N/A |
9/30/2016 | 4 | -9 | -9 | -8 | N/A |
6/30/2016 | 4 | -7 | N/A | -6 | N/A |
3/31/2016 | 4 | -9 | N/A | -8 | N/A |
12/31/2015 | 4 | -11 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: B8FE's forecast earnings growth (48% per year) is above the savings rate (0.03%).
Earnings vs Market: B8FE's earnings (48% per year) are forecast to grow faster than the German market (14.7% per year).
High Growth Earnings: B8FE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: B8FE's revenue (22.4% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: B8FE's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if B8FE's Return on Equity is forecast to be high in 3 years time